Lamdong Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000LDP3
VND
8,600.00
-2100 (-19.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lamdong Pharmaceutical JSC

Why is Lamdong Pharmaceutical JSC ?

1
The company has declared Positive results for the last 9 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at VND 7,683.15 MM
  • NET PROFIT(HY) Higher at VND 22,357.63 MM
  • ROCE(HY) Highest at 18.67%
2
With ROE of 8.12%, it has a attractive valuation with a 0.00 Price to Book Value
  • Over the past year, while the stock has generated a return of -22.52%, its profits have risen by 248.6%
3
Below par performance in long term as well as near term
  • Along with generating -22.52% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Lamdong Pharmaceutical JSC should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Lamdong Pharmaceutical JSC for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Lamdong Pharmaceutical JSC
-100.0%
-1.32
46.96%
Vietnam VN Ho Chi Minh Index
38.87%
1.81
21.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-2.40%
EBIT Growth (5y)
22.02%
EBIT to Interest (avg)
-2.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
1.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.91%
ROE (avg)
6.47%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
2.91
EV to EBITDA
2.04
EV to Capital Employed
0.27
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.18%
ROE (Latest)
8.12%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
OPERATING CASH FLOW(Y)

Highest at VND 7,683.15 MM

NET PROFIT(HY)

Higher at VND 22,357.63 MM

ROCE(HY)

Highest at 18.67%

RAW MATERIAL COST(Y)

Fallen by -7.89% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 16.48 %

-11What is not working for the Company
PRE-TAX PROFIT(Q)

At VND 1,493.15 MM has Fallen at -78.2%

INTEREST(Q)

At VND 1,452.35 MM has Grown at 17.05%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.13 times

NET PROFIT(Q)

Lowest at VND 935.46 MM

EPS(Q)

Lowest at VND 49.95

Here's what is working for Lamdong Pharmaceutical JSC

Operating Cash Flow
Highest at VND 7,683.15 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Debt-Equity Ratio
Lowest at 16.48 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -7.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Lamdong Pharmaceutical JSC

Pre-Tax Profit
At VND 1,493.15 MM has Fallen at -78.2%
over average net sales of the previous four periods of VND 6,850.1 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (VND MM)

Net Profit
At VND 935.46 MM has Fallen at -86.34%
over average net sales of the previous four periods of VND 6,850.1 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (VND MM)

Interest
At VND 1,452.35 MM has Grown at 17.05%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Net Profit
Lowest at VND 935.46 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (VND MM)

EPS
Lowest at VND 49.95
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Inventory Turnover Ratio
Lowest at 3.13 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio